Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats

Neuropharmacology

Volumn 40, Issue 6, 2001, Pages 792-805

  Boye, Sandra M ^a   Grant, Rebecca J ^a   Clarke, Paul B S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

6 Hydroxydopamine; Amphetamine; Eticlopride; Locomotion; Nicotine; Nucleus accumbens

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; ETICLOPRIDE; IODINE 125; NICOTINE; OXIDOPAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; INNERVATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ADRENERGIC AGENTS; ANIMALS; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; NUCLEUS ACCUMBENS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035011105     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00003-X     Document Type: Article

References (64)

1. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. Journal of Neurochemistry. 48:1987;390-399.
2. 3 receptor antagonists do not block nicotine induced hyperactivity in rats. Psychopharmacology. 119:1995;213-221.
3. Balfour D.J., Wright A.E., Benwell M.E., Birrell C.E. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioural Brain Research. 113:2000;73-83.
4. Benwell M.E.M., Balfour D.J.K., Lucchi H.M. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology. 112:1993;467-474.
5. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse. 12:1992;27-36.
6. Burns L.H., Annett L., Kelley A.E., Everitt B.J., Robbins T.W. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: Implication for limbic-striatal interactions. Behavioural Neuroscience. 110:1996;60-73.
7. Campbell A., Villavicencio A.T., Yeghiayan S.K., Balikian R., Baldessarini R.J. Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Research. 771:1997;55-62.
8. Canales J.J., Iversen S.D. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors. Synapse. 36:2000;297-306.
9. Carlezon W.A., Devine D.P., Wise R.A. Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology. 122:1995;194-197.
10. Chapman M.A., Zahm D.S. Altered Fos-like immunoreactivity in terminal regions of the mesotelencephalic dopamine system is associated with reappearance of tyrosine hydroxylase immunoreactivity at the sites of focal 6-hydroxydopamine lesions in the nucleus accumbens. Brain Research. 736:1996;270-279.
11. Choi K.H., Zarandi B., Todd K.G., Biondo A.M., Greenshaw A.J. Effects of AMPA/kainate receptor blockade on responses to dopamine receptor agonists in the core and shell of the rat nucleus accumbens. Psychopharmacology. 150:2000;102-111.
12. Clarke P.B.S., Jakubovic A., Fibiger H.C. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of D-amphetamine and apomorphine. Psychopharmacology. 96:1988;511-520.
13. Clarke P.B.S., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. Journal of Pharmacology and Experimental Therapeutics. 246:1988;701-708.
14. Corrigall W.A., Coen K.M. Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology. 104:1991;171-176.
15. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
16. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research. 653:1994;278-284.
17. 125I]RTI-55. Brain Research. 690:1995;217-224.
18. Delfs J.M., Zhu Y., Druhan J.P., Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: Anterograde and retrograde tract- tracing studies in the rat. Brain Research. 806:1998;127-140.
19. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology. 375:1999;13-30.
20. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. European Journal of Pharmacology. 393:2000;295-314.
21. Essman W.D., McGonigle P., Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and D-amphetamine. Psychopharmacology. 112:1993;233-241.
22. Fink J.S., Smith G.P. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine. Brain Research. 201:1980;107-127.
23. Fletcher P.J., Sabijan M.S., DeSousa N.J. Injections of D-amphetamine into the ventral pallidum increase locomotor activity and responding for conditioned reward: a comparison with injections into the nucleus accumbens. Brain Research. 805:1998;29-40.
24. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 96:2000;651-656.
25. 2 receptors in the nucleus accumbens in mediating reward. Journal of Neuroscience. 17:1997;8580-8587.
26. Jones G.H., Robbins T.W. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacology, Biochemistry and Behavior. 43:1992;887-895.
27. Joyce E.M., Stinus L., Iversen S.D. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology. 22:1983;1141-1145.
28. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Experimental Neurology. 113:1991;261-276.
29. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. European Journal of Pharmacology. 40:1976;45-56.
30. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research. 94:1975;507-522.
31. King D., Zigmond M.J., Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:1997;141-153.
32. Koob G.F., Stinus L., Le Moal M. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behavioural Brain Research. 3:1981;341-359.
33. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
34. 2 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology. 126:1996;185-190.
35. Louis M., Clarke P.B.S. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology. 37:1998;1503-1513.
36. Maldonado-Irizarry C.S., Kelley A.E. Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions. Psychopharmacology. 116:1994;65-72.
37. Maldonado-Irizarry C.S., Kelley A.E. Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Research Bulletin. 38:1995;551-559.
38. Menzaghi F., Whelan K.T., Risbrough V.B., Rao T.S., Lloyd G.K. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. Journal of Pharmacology and Experimental Therapeutics. 280:1997;384-392.
39. Meredith G.E., Ypma P., Zahm D.S. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens. Journal of Neuroscience. 15:1995;3808-3820.
40. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
41. O'Neill M.F., Dourish C.T., Iversen S.D. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology. 104:1991;343-350.
42. Panagis G., Nisell M., Nomikos G.G., Chergui K., Svensson T.H. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Research. 730:1996;133-142.
43. Parkinson J.A., Olmstead M.C., Burns L.H., Robbins T.W., Everitt B.J. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive Pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. Journal of Neuroscience. 19:1999;2401-2411.
44. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed:1997;Academic Press, San Diego, CA.
45. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. Journal of Pharmacology and Experimental Therapeutics. 275:1995;1019-1029.
46. Pijnenburg A.J., Honig W.M., van Rossum J.M. Inhibition of D-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia. 41:1975;87-95.
47. Pijnenburg A.J., Honig W.M., van Rossum J.M. Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia. 41:1975;175-180.
48. Pulvirenti L., Berrier R., Kreifeldt M., Koob G.F. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat. Brain Research. 664:1994;231-236.
49. Reavill C., Stolerman I.P. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. British Journal of Pharmacology. 99:1990;273-278.
50. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Progress in Neurobiology. 50:1996;275-331.
51. Sokolowski J.D., Salamone J.D. The role of accumbens dopamine in lever pressing and response allocation: Effects of 6-OHDA injected into core and dorsomedial shell. Pharmacology, Biochemistry and Behavior. 59:1998;557-566.
52. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacology, Biochemistry and Behavior. 58:1997;933-945.
53. Swerdlow N.R., Vaccarino F.J., Amalric M., Koob G.F. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacology, Biochemistry and Behavior. 25:1986;233-248.
54. 4 dopamine receptors in fibroblast and dopaminergic cell lines. Journal of Pharmacology and Experimental Therapeutics. 268:1994;495-502.
55. Vezina P., Hervé D., Glowinski J., Tassin J.P. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neuroscience Letters. 168:1994;111-114.
56. Weiner I., Gal G., Rawlins J.N.P., Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behavioural Brain Research. 81:1996;123-133.
57. Weissenborn R., Winn P. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens. Behavioural Brain Research. 51:1992;127-137.
58. West C.H.K., Boss-Williams K.A., Weiss J.M. Motor activation by amphetamine infusion into nucleus accumbens core and shell subregions of rats differentially sensitive to dopaminergic drugs. Behavioural Brain Research. 98:1999;155-165.
59. Wise R.A. The brain and reward. Liebman J.M., Cooper S.J. The Neuropharmacological Basis of Reward. 1989;377-424 Oxford University Press, Oxford.
60. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Review. 94:1987;469-492.
61. Zahm D.S. Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopamine into the ventral mesencephalon. Brain Research. 552:1991;164-169.
62. Zahm D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neuroscience and Biobehavioural Reviews. 24:2000;85-105.
63. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.
64. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends in Neurosciences. 13:1990;290-296.